Evidence map›Paper›PMID 29659149›Full record

ArticleInfluenza and other respiratory viruses2018

Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017.

Marta Valenciano, Esther Kissling, Amparo Larrauri, Baltazar Nunes, Daniela Pitigoi, Joan O'Donnell, Annicka Reuss, Judit Krisztina Horváth, Iwona Paradowska-Stankiewicz, Caterina Rizzo and 21 more

Abstract readMulticenter Study
In one paragraph

Article in Influenza and other respiratory viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  12. Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
  13. Influenza Vaccine Effectiveness: New Insights and Challenges.Cold Spring Harbor perspectives in medicine · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Baseline characteristics and clinical symptoms related to respiratory viruses identified among patients presenting with influenza-like illness in primary care.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2019
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Marta ValencianoEpidemiology, Epiconcept, Paris, France.ORCID http://orcid.org/0000-0002-2056-1062
Esther KisslingEpidemiology, Epiconcept, Paris, France.ORCID http://orcid.org/0000-0001-7188-8404
Amparo LarrauriNational Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-1704-2245
Baltazar NunesDepartment of Epidemiology, Instituto Nacional de Saúde, Doctor Ricardo Jorge, Lisboa, Portugal.ORCID http://orcid.org/0000-0001-6230-7209
Daniela PitigoiUniversity of Medicine and Pharmacy Carol Davila, Bucharest, Romania.ORCID http://orcid.org/0000-0003-4118-8268
Joan O'DonnellHealth Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.
Annicka ReussDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Judit Krisztina HorváthDepartment of Disease Prevention and Surveillance, National Centre for Epidemiology, Budapest, Hungary.
Iwona Paradowska-StankiewiczNational Institute of Public Health - National Institute of Hygiene, Warsaw, Poland.
Caterina RizzoNational Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy.
Alessandra FalchiUniversité de Corse-Inserm, Corte, France.
Isabelle DaviaudOpen Rome, Réseau des GROG, Paris, France.
Mia BryttingThe Public Health Agency of Sweden, Stockholm, Sweden.
Adam MeijerCentre for Infectious Disease Control, National Institute of Public Health and Environment (RIVM), Bilthoven, The Netherlands.
Bernard KaicHrvatski zavod za javno zdravstvo, Zagreb, Croatia.
Alin GherasimNational Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain.
Ausenda MachadoDepartment of Epidemiology, Instituto Nacional de Saúde, Doctor Ricardo Jorge, Lisboa, Portugal.ORCID http://orcid.org/0000-0002-1849-1499
Alina IvanciucCantacuzino Institute, National Institute of Research - Development for Microbiology and Immunology, Bucharest, Romania.
Lisa DomeganHealth Service Executive - Health Protection Surveillance Centre, Dublin, Ireland.
Brunhilde SchweigerDepartment for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Annamária FerencziDepartment of Disease Prevention and Surveillance, National Centre for Epidemiology, Budapest, Hungary.
Monika KorczyńskaNational Institute of Public Health - National Institute of Hygiene, Warsaw, Poland.
Antonino BellaNational Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy.ORCID http://orcid.org/0000-0002-6615-4227
Ana-Maria VilcuInstitut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), UPMC Univ Paris 06, INSERM, Sorbonne Universités, Paris, France.
Anne MosnierOpen Rome, Réseau des GROG, Paris, France.
Katherina ZakikhanyThe Public Health Agency of Sweden, Stockholm, Sweden.
Marit de LangeCentre for Infectious Disease Control, National Institute of Public Health and Environment (RIVM), Bilthoven, The Netherlands.
Sanja Kurečić FilipovićovićHrvatski zavod za javno zdravstvo, Zagreb, Croatia.
Kari JohansenEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Alain MorenEpidemiology, Epiconcept, Paris, France.
I-MOVE primary care multicentre case-control team

Funding

European Centre for Disease Prevention and Control ECDC/2014/026European Union's Horizon 2020 research and innovation programme 634446WHO-EURO
6 · The paper itself

Abstract

backgroundResults of previous influenza vaccination effects on current season influenza vaccine effectiveness (VE) are inconsistent.

objectivesTo explore previous influenza vaccination effects on current season VE among population targeted for vaccination.

methodsWe used 2011/2012 to 2016/2017 I-MOVE primary care multicentre test-negative data. For each season, we compared current season adjusted VE (aVE) between individuals vaccinated and unvaccinated in previous season. Using unvaccinated in both seasons as a reference, we then compared aVE between vaccinated in both seasons, current only, and previous only.

resultsWe included 941, 2645 and 959 influenza-like illness patients positive for influenza A(H1N1)pdm09, A(H3N2) and B, respectively, and 5532 controls. In 2011/2012, 2014/2015 and 2016/2017, A(H3N2) aVE point estimates among those vaccinated in previous season were -68%, -21% and -19%, respectively; among unvaccinated in previous season, these were 33%, 48% and 46%, respectively (aVE not computable for influenza A(H1N1)pdm09 and B). Compared to current season vaccination only, VE for both seasons' vaccination was (i) similar in two of four seasons for A(H3N2) (absolute difference [ad] 6% and 8%); (ii) lower in three of four seasons for influenza A(H1N1)pdm09 (ad 18%, 26% and 29%), in two seasons for influenza A(H3N2) (ad 27% and 39%) and in two of three seasons for influenza B (ad 26% and 37%); (iii) higher in one season for influenza A(H1N1)pdm09 (ad 20%) and influenza B (ad 24%).

conclusionsWe did not identify any pattern of previous influenza vaccination effect. Prospective cohort studies documenting influenza infections, vaccinations and vaccine types are needed to understand previous influenza vaccinations' effects.

Indexed as

AdolescentAdultAgedAged, 80 and overChildFemaleHumansInfluenza, HumanInfluenza VaccinesMaleMiddle AgedTreatment OutcomeYoung AdultInfluenza Vaccinescase-control studyinfluenzainfluenza vaccinemulticentre studyvaccine effectiveness

Identifiers

PMID29659149
PMCPMC6086844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.